June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Integrated genomics and proteomics analysis reveal the regulatory role of miR-10b targets in normal and diabetic human limbal epithelial cells
Author Affiliations & Notes
  • Nagendra Verma
    Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States
    Regenerative Medicine Institute, Cedars-Sinai Medical Center Board of Governors Regenerative Medicine Institute, Los Angeles, California, United States
  • Adam Poe
    Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States
    Regenerative Medicine Institute, Cedars-Sinai Medical Center Board of Governors Regenerative Medicine Institute, Los Angeles, California, United States
  • Andrew Fealy
    Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States
    Regenerative Medicine Institute, Cedars-Sinai Medical Center Board of Governors Regenerative Medicine Institute, Los Angeles, California, United States
  • Mariam Ebrahami
    Regenerative Medicine Institute, Cedars-Sinai Medical Center Board of Governors Regenerative Medicine Institute, Los Angeles, California, United States
    University of California Los Angeles, Los Angeles, California, United States
  • Anokhi Patel
    Regenerative Medicine Institute, Cedars-Sinai Medical Center Board of Governors Regenerative Medicine Institute, Los Angeles, California, United States
    University of California Los Angeles, Los Angeles, California, United States
  • Ying Song Xue
    Genomics Core, Cedars-Sinai Medical Center, Los Angeles, California, United States
  • Santiskulvong Chintda
    Genomics Core, Cedars-Sinai Medical Center, Los Angeles, California, United States
  • Alex Rajewski
    Genomics Core, Cedars-Sinai Medical Center, Los Angeles, California, United States
  • Sun Ren
    Bioinformatics Shared Resource, Cedars-Sinai Medical Center, Los Angeles, California, United States
  • Kevin Tseng
    Bioinformatics Shared Resource, Cedars-Sinai Medical Center, Los Angeles, California, United States
  • Sungyong You
    Bioinformatics Shared Resource, Cedars-Sinai Medical Center, Los Angeles, California, United States
  • Alexander V. Ljubimov
    Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States
    Regenerative Medicine Institute, Cedars-Sinai Medical Center Board of Governors Regenerative Medicine Institute, Los Angeles, California, United States
  • Mehrnoosh Saghizadeh
    Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States
    Regenerative Medicine Institute, Cedars-Sinai Medical Center Board of Governors Regenerative Medicine Institute, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Nagendra Verma None; Adam Poe None; Andrew Fealy None; Mariam Ebrahami None; Anokhi Patel None; Ying Song Xue None; Santiskulvong Chintda None; Alex Rajewski None; Sun Ren None; Kevin Tseng None; Sungyong You None; Alexander V. Ljubimov None; Mehrnoosh Saghizadeh None
  • Footnotes
    Support  NIH grants R01 EY025377 and EY029829
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3101. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nagendra Verma, Adam Poe, Andrew Fealy, Mariam Ebrahami, Anokhi Patel, Ying Song Xue, Santiskulvong Chintda, Alex Rajewski, Sun Ren, Kevin Tseng, Sungyong You, Alexander V. Ljubimov, Mehrnoosh Saghizadeh; Integrated genomics and proteomics analysis reveal the regulatory role of miR-10b targets in normal and diabetic human limbal epithelial cells. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3101.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : MicroRNA-10b (miR-10b) is up-regulated in the limbus vs central human cornea and also in diabetic (DM) vs normal (N) limbus, which may contribute to limbal cell function and diabetic corneal disease, respectively. Our aim was to identify miR-10b target genes/proteins using integrated genomic and proteomic analyses to elucidate its role in the normal and diabetic limbus

Methods : Human autopsy N and DM corneas were procured by the National Disease Research Interchange (NDRI) in Optisol medium. In vitro experiments were performed with stem cell-enriched human N and DM primary limbal epithelial cells (LECs). miRNA transfection was performed using Lipofectamine RNAiMAX. Normal LECs were transfected with miR-10b mimic (M), or its mimic control (MC). At day 3 post-transfection, cells were harvested for total RNA isolation using Trizol for next-generation RNA sequencing (RNA-seq). A matching set of transfected LECs was collected and cell lysates were prepared for proteomics analysis

Results : Sets of 661 mRNAs (FC of ± 2, 305 up- and 356 down-regulated) and 144 proteins (FC of ± 1.5, 72 up- and 72 down-regulated) were identified as differentially expressed in miR-10bM vs. MC with adjusted p < 0.05 using RNA-seq and proteomics analyses, respectively. Combined proteomics and genomics analysis revealed a total of 17 overlapping genes as potential targets of miR-10b, all considered putative or validated targets in the literature. Additionally, pathway analysis of proteomics and transcriptomics data revealed significant changes in multiple signaling pathways such as cell cycle, DNA repair and replication, Wnt and TP53 signaling. Overexpression of miR-10b in primary N and DM LECs significantly decreased expression levels of target proteins GCLM, CMPK1, Lig1, and TPM4 by western blot and immunostaining. In addition down-regulation of miR-10b in DM organ-cultured corneas using miR-10b inhibitor increased expression levels of TPM4 and Lig1 involved in DNA repair and replication by immunostaining

Conclusions : In conclusion, by using integrated genomic and proteomic analyses of cultured N and DM LECs, potential key target genes of miR-10b were revealed as well as the underlying pathways affecting human LEC function. Further analysis of promising targets may improve our understanding of the molecular mechanisms underlying diabetic corneal alterations and wound healing

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×